Pharmaceutical compositions comprising forms of 5-azacytidine
US9192620B2 · kind B2 · utility
0Cited by
28References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2013 |
| Grant date | Nov 24, 2015 |
| Priority date | — |
| Expiry date | Mar 23, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel polymorphic and pseudopolymorphic crystalline forms of 5-azacyditine, along with methods for preparing said forms, wherein 5-azacytidine is represented by the formula:The invention also includes pharmaceutical compositions comprising said forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.